paroxetine has been researched along with Delayed Effects, Prenatal Exposure in 39 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 10 (25.64) | 18.2507 |
2000's | 16 (41.03) | 29.6817 |
2010's | 12 (30.77) | 24.3611 |
2020's | 1 (2.56) | 2.80 |
Authors | Studies |
---|---|
Breur, JMPJ; Leerssen, ECM; Tak, RO | 1 |
Aucott, L; Fitton, CA; Fleming, M; Mackay, DF; McLay, JS; Pell, JP; Steiner, MFC | 1 |
Clinton, SM; Glover, ME; Jackson, NL; McCoy, CR; Shupe, EA; Unroe, KA | 1 |
Blackwell, KA; Forray, A; Glover, J; Yonkers, KA | 1 |
Aydin, B; Beken, S; Dilli, D; Dinlen, N; Okumuş, N; Zenciroğlu, A | 1 |
Akil, H; Clinton, SM; Cohen, JL; Fant, AD; Glover, ME; Jackson, NL; Pugh, PC | 1 |
Kennedy, D | 1 |
Bakker, MK; Buys, CH; de Jong-van den Berg, LT; de Walle, HE; Kerstjens-Frederikse, WS | 1 |
Ellfolk, M; Malm, H | 1 |
Favrelière, S; Jaafari, N; Nourrisson, A; Pérault Pochat, MC | 1 |
Akulova, VK; Fedotova, YO; Ordian, NÉ; Pivina, SG | 1 |
Dilillo, D; Penagini, F; Pogliani, L; Schneider, L; Zuccotti, GV | 1 |
Coffey, DB; John, N; Potter, PO | 1 |
Byatt, N; Deligiannidis, KM; Freeman, MP | 1 |
Kelly, PA; McBean, DE; Olverman, HJ; Quate, L; Ritchie, IM | 1 |
Coombs, RC; Isbister, GK; Jaiswal, S | 1 |
Dahlem, P; Duijvestijn, YC; Kalmeijer, MD; Passier, AL; Smiers, F | 1 |
Battaglia, G; Carrasco, GA; Chen, Z; Landry, M; Van de Kar, LD; Waimey, K | 1 |
Bertilsson, L; Kytölä, J; Laine, K | 1 |
Clarke, P; Haddad, PM; Pal, BR; Sridhiran, S; Wieck, A | 1 |
Källén, B; Otterblad Olausson, P | 1 |
Thormahlen, GM | 1 |
Blanco, CE; Desbonnet, L; Leonard, BE; Myint, AM; Prickaerts, J; Scheepens, A; Steinbusch, HW; Van den Hove, DL | 1 |
González, MI; Leret, ML; Molina-Holgado, E; Molina-Holgado, F; Reader, TA | 1 |
Kelly, PA; McBean, DE; Ritchie, IM; Sharkey, J | 1 |
Caldecott-Hazard, S; Weissman, AD | 1 |
Barnes, GA; McCook, EC; Seidler, FJ; Slotkin, TA | 1 |
Ahlner, J; Dahl, ML; Olhager, E | 1 |
Kamei, K; Kitera, K; Mikuni, M; Muneoka, K; Ogawa, T; Takahashi, K; Takigawa, M | 1 |
McReynolds, AM; Meyer, JS | 1 |
Lamberg, L | 1 |
Christensen, HD; Coleman, FH; Gonzalez, CL; Rayburn, WF | 1 |
Hagino, Y; Kodama, Y; Nonaka, R; Watanabe, M | 1 |
Friedman, EH | 1 |
Kamei, K; Kato, H; Mimura, Y; Muneoka, K; Ogawa, T; Takigawa, M | 1 |
Bosschaart, AN; Kok-Van Rooij, GW; Nijhuis, IJ | 1 |
Ali, SF; Seidler, FJ; Slikker, W; Slotkin, TA; Xu, Z | 1 |
Quartermain, D; Shemer, AV; Whitaker-Azmitia, PM | 1 |
6 review(s) available for paroxetine and Delayed Effects, Prenatal Exposure
Article | Year |
---|---|
In utero exposure to antidepressant medication and neonatal and child outcomes: a systematic review.
Topics: Antidepressive Agents; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Child; Conduct Disorder; Congenital Abnormalities; Depressive Disorder; Female; Gestational Age; Heart Defects, Congenital; Humans; Infant, Newborn; Neurodevelopmental Disorders; Paroxetine; Pregnancy; Pregnancy Complications; Premature Birth; Prenatal Exposure Delayed Effects; Risk Factors | 2020 |
Antidepressant use in pregnant and postpartum women.
Topics: Antidepressive Agents; Depression, Postpartum; Depressive Disorder; Female; Heart Defects, Congenital; Humans; Infant, Newborn; Paroxetine; Persistent Fetal Circulation Syndrome; Pregnancy; Pregnancy Complications; Prenatal Exposure Delayed Effects | 2014 |
Risks associated with in utero and lactation exposure to selective serotonin reuptake inhibitors (SSRIs).
Topics: Adult; Breast Feeding; Cardiovascular Abnormalities; Congenital Abnormalities; Female; Fluoxetine; Humans; Hypertension, Pulmonary; Infant, Newborn; Lactation; Maternal Exposure; Paroxetine; Pregnancy; Prenatal Exposure Delayed Effects; PubMed; Respiratory Distress Syndrome, Newborn; Risk Assessment; Selective Serotonin Reuptake Inhibitors | 2010 |
[Treatment of depressed pregnant women by selective serotonin reuptake inhibitors: risk for the foetus and the newborn].
Topics: Abnormalities, Drug-Induced; Antidepressive Agents, Second-Generation; Depressive Disorder; Female; Gestational Age; Humans; Infant, Newborn; Paroxetine; Pregnancy; Pregnancy Complications; Prenatal Exposure Delayed Effects; Risk; Secondary Prevention; Selective Serotonin Reuptake Inhibitors | 2010 |
Antidepressant use in pregnancy: a critical review focused on risks and controversies.
Topics: Abnormalities, Drug-Induced; Antidepressive Agents; Depressive Disorder; Female; Humans; Infant, Newborn; Paroxetine; Persistent Fetal Circulation Syndrome; Pregnancy; Pregnancy Complications; Pregnancy Trimester, First; Prenatal Exposure Delayed Effects; Risk Factors; Selective Serotonin Reuptake Inhibitors | 2013 |
Paroxetine use during pregnancy: is it safe?
Topics: Female; Humans; Infant, Newborn; Paroxetine; Pregnancy; Prenatal Exposure Delayed Effects; Risk Factors | 2006 |
33 other study(ies) available for paroxetine and Delayed Effects, Prenatal Exposure
Article | Year |
---|---|
Severe transient neonatal long QT syndrome due to maternal paroxetine usage: a case report.
Topics: Electrocardiography; Female; Humans; Infant, Newborn; Long QT Syndrome; Maternal Exposure; Paroxetine; Pregnancy; Prenatal Exposure Delayed Effects; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index | 2019 |
Perinatal exposure to the SSRI paroxetine alters the methylome landscape of the developing dentate gyrus.
Topics: Animals; Animals, Newborn; Antidepressive Agents; Behavior, Animal; Dentate Gyrus; Depression; Disease Models, Animal; DNA (Cytosine-5-)-Methyltransferases; DNA Methyltransferase 3A; Female; Gene Expression; Male; Paroxetine; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Sprague-Dawley; RNA, Small Interfering; Selective Serotonin Reuptake Inhibitors; Sex Factors | 2019 |
Treacher Collins syndrome with multiple congenital heart defects after paroxetine exposure: case report.
Topics: Abnormalities, Multiple; Adult; Fatal Outcome; Female; Heart Defects, Congenital; Humans; Infant, Newborn; Male; Mandibulofacial Dysostosis; Paroxetine; Pregnancy; Prenatal Exposure Delayed Effects; Selective Serotonin Reuptake Inhibitors | 2014 |
Early-life exposure to the SSRI paroxetine exacerbates depression-like behavior in anxiety/depression-prone rats.
Topics: Amygdala; Animals; Animals, Newborn; Anxiety Disorders; Depressive Disorder; Disease Models, Animal; Exploratory Behavior; Female; Gene Expression Regulation, Developmental; Genetic Predisposition to Disease; Hippocampus; Male; Maternal Behavior; Paroxetine; Pregnancy; Prenatal Exposure Delayed Effects; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors | 2015 |
Re: alcohol and pregnancy: the pivotal role of the obstetrician.
Topics: Alcohol Drinking; Alcohol-Induced Disorders; Antidepressive Agents, Second-Generation; Female; Fetal Alcohol Spectrum Disorders; Humans; Obstetrics; Paroxetine; Physician's Role; Pregnancy; Prenatal Exposure Delayed Effects; Risk Assessment | 2008 |
First-trimester use of paroxetine and congenital heart defects: a population-based case-control study.
Topics: Adult; Alcohol Drinking; Antidepressive Agents, Second-Generation; Case-Control Studies; Child; Female; Heart Septal Defects, Atrial; Humans; Infant, Newborn; Maternal Age; Netherlands; Paroxetine; Pregnancy; Pregnancy Trimester, First; Prenatal Exposure Delayed Effects; Selective Serotonin Reuptake Inhibitors; Smoking; Vital Statistics; Young Adult | 2010 |
[Influence of fluoxetine and paroxetine on anxiety-like behavior in young and adult prenatally stressed male rats].
Topics: Age Factors; Animals; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Anxiety; Behavior, Animal; Female; Fluoxetine; Male; Paroxetine; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Sex Factors; Stress, Psychological | 2011 |
Paroxetine and neonatal withdrawal syndrome.
Topics: Adult; Antidepressive Agents, Second-Generation; Depression; Female; Humans; Infant, Newborn; Male; Neonatal Abstinence Syndrome; Paroxetine; Pregnancy; Prenatal Exposure Delayed Effects | 2010 |
Onset of abnormal movements and cardiovascular symptoms after acute change in complex polypharmacy in a child with attention-deficit/hyperactivity disorder and mood symptoms.
Topics: Adrenergic alpha-Agonists; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Asthma; Attention Deficit Disorder with Hyperactivity; Cardiovascular Diseases; Chest Pain; Child; Dyskinesia, Drug-Induced; Family; Female; Guanfacine; Humans; Lithium Chloride; Male; Mood Disorders; Neuropsychological Tests; Obesity; Paroxetine; Piperazines; Polypharmacy; Pregnancy; Prenatal Exposure Delayed Effects; Psychomotor Agitation; Quinolones; Selective Serotonin Reuptake Inhibitors; Smoking; Social Environment | 2012 |
Functional consequences of perinatal exposure to 3,4-methylenedioxymethamphetamine in rat brain.
Topics: Adrenergic Uptake Inhibitors; Animals; Animals, Newborn; Binding, Competitive; Brain; Female; Glucose; Male; N-Methyl-3,4-methylenedioxyamphetamine; Paroxetine; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Sprague-Dawley; Serotonin; Time Factors; Tritium | 2002 |
Paroxetine withdrawal in a neonate with historical and laboratory confirmation.
Topics: Adult; Antidepressive Agents, Second-Generation; Female; Humans; Hydroxyindoleacetic Acid; Infant, Newborn; Male; Neonatal Abstinence Syndrome; Paroxetine; Pregnancy; Prenatal Exposure Delayed Effects | 2003 |
Neonatal intraventricular haemorrhage associated with maternal use of paroxetine.
Topics: Cerebral Hemorrhage; Contraindications; Female; Humans; Infant, Newborn; Male; Paroxetine; Pregnancy; Pregnancy Complications; Prenatal Exposure Delayed Effects; Selective Serotonin Reuptake Inhibitors | 2003 |
Prenatal cocaine exposure potentiates paroxetine-induced desensitization of 5-HT2A receptor function in adult male rat offspring.
Topics: Adrenocorticotropic Hormone; Animals; Cocaine; Corticosterone; Drug Synergism; Female; Male; Oxytocin; Paroxetine; Pregnancy; Prenatal Exposure Delayed Effects; Protein Binding; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Serotonin 5-HT2 Receptor Antagonists | 2004 |
Severe adverse effects in a newborn with two defective CYP2D6 alleles after exposure to paroxetine during late pregnancy.
Topics: Alleles; Cytochrome P-450 CYP2D6; Female; Humans; Infant, Newborn; Nervous System Diseases; Paroxetine; Pregnancy; Prenatal Exposure Delayed Effects | 2004 |
Neonatal symptoms following maternal paroxetine treatment: serotonin toxicity or paroxetine discontinuation syndrome?
Topics: Adult; Antidepressive Agents, Second-Generation; Depressive Disorder; Diagnosis, Differential; Female; Humans; Infant, Newborn; Neonatal Abstinence Syndrome; Paroxetine; Pregnancy; Prenatal Exposure Delayed Effects; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome | 2005 |
Antidepressant drugs during pregnancy and infant congenital heart defect.
Topics: Abnormalities, Drug-Induced; Antidepressive Agents; Clomipramine; Female; Heart Defects, Congenital; Humans; Paroxetine; Pregnancy; Prenatal Exposure Delayed Effects; Sweden | 2006 |
SSRI antidepressants and birth defects.
Topics: Abnormalities, Drug-Induced; Antidepressive Agents, Second-Generation; Clinical Trials as Topic; Cohort Studies; Cost-Benefit Analysis; Denmark; Depression; Female; Heart Defects, Congenital; Humans; Infant, Newborn; Paroxetine; Pregnancy; Prenatal Exposure Delayed Effects; Selective Serotonin Reuptake Inhibitors; Sweden; Teratogens; United States | 2006 |
Prenatal maternal paroxetine treatment and neonatal mortality in the rat: a preliminary study.
Topics: Animals; Animals, Newborn; Female; Male; Paroxetine; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Inbred F344; Selective Serotonin Reuptake Inhibitors; Stress, Psychological | 2008 |
Distribution of indoleamines and [3H]paroxetine binding in rat brain regions following acute or perinatal delta 9-tetrahydrocannabinol treatments.
Topics: Animals; Brain; Dronabinol; Female; Gyrus Cinguli; Hippocampus; Hydroxyindoleacetic Acid; Hypothalamus, Anterior; Locus Coeruleus; Male; Neostriatum; Paroxetine; Pregnancy; Prenatal Exposure Delayed Effects; Raphe Nuclei; Rats; Rats, Wistar; Serotonin; Substantia Nigra; Tritium | 1993 |
Alterations in local cerebral blood flow in mature rats following prenatal exposure to cocaine.
Topics: Animals; Autoradiography; Brain; Brain Chemistry; Cerebrovascular Circulation; Cocaine; Female; Glucose; Male; Paroxetine; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Sprague-Dawley | 1994 |
In utero methamphetamine effects: I. Behavior and monoamine uptake sites in adult offspring.
Topics: Animals; Behavior, Animal; Biogenic Monoamines; Brain; Female; Male; Mazindol; Methamphetamine; Paroxetine; Piperazines; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Sprague-Dawley | 1993 |
Programming of brainstem serotonin transporter development by prenatal glucocorticoids.
Topics: Animals; Binding Sites; Body Weight; Brain Stem; Carrier Proteins; Cell Differentiation; Cell Division; Dexamethasone; Female; Glucocorticoids; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Neurons; Paroxetine; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Tritium | 1996 |
Paroxetine withdrawal syndrome in a neonate.
Topics: Adult; Antidepressive Agents, Second-Generation; Female; Humans; Infant, Newborn; Male; Paroxetine; Pregnancy; Prenatal Exposure Delayed Effects; Substance Withdrawal Syndrome | 1997 |
Prenatal dexamethasone exposure alters brain monoamine metabolism and adrenocortical response in rat offspring.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adrenal Cortex; Aging; Analysis of Variance; Animals; Biogenic Monoamines; Brain; Corticosterone; Defecation; Dexamethasone; Dopamine; Female; Gestational Age; Homovanillic Acid; Hydroxyindoleacetic Acid; Male; Motor Activity; Organ Specificity; Paroxetine; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Sprague-Dawley; Serotonin | 1997 |
Effects of prenatal cocaine exposure on serotonin and norepinephrine transporter density in the rat brain.
Topics: Aging; Animals; Brain; Carrier Proteins; Cocaine; Female; Fluoxetine; Male; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Organ Specificity; Paroxetine; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Sprague-Dawley; Reference Values; Serotonin; Serotonin Plasma Membrane Transport Proteins; Symporters | 1998 |
Safety of antidepressant use in pregnant and nursing women.
Topics: Antidepressive Agents; Breast Feeding; Depression, Postpartum; Depressive Disorder; Female; Humans; Infant, Newborn; Lactation; Paroxetine; Pregnancy; Pregnancy Complications; Prenatal Exposure Delayed Effects; Risk; Selective Serotonin Reuptake Inhibitors; Sleep | 1999 |
Behavioral changes in developing mice after prenatal exposure to paroxetine (Paxil)
Topics: Aggression; Animals; Animals, Newborn; Anxiety; Behavior, Animal; Body Weight; Depression; Exploratory Behavior; Female; Homing Behavior; Litter Size; Male; Maternal Exposure; Mice; Motor Activity; Paroxetine; Play and Playthings; Pregnancy; Prenatal Exposure Delayed Effects; Random Allocation; Selective Serotonin Reuptake Inhibitors; Sleep; Time Factors; Vocalization, Animal | 1999 |
The distribution of serotonergic nerves in microencephalic rats treated prenatally with methylazoxymethanol.
Topics: Animals; Autoradiography; Binding Sites; Brain; Carrier Proteins; Cerebellum; Cerebral Cortex; Female; Hippocampus; Membrane Glycoproteins; Membrane Transport Proteins; Methylazoxymethanol Acetate; Microcephaly; Nerve Tissue Proteins; Neurons; Nucleus Accumbens; Paroxetine; Pregnancy; Prenatal Exposure Delayed Effects; Raphe Nuclei; Rats; Rats, Wistar; RNA, Messenger; Serotonin; Serotonin Plasma Membrane Transport Proteins; Thalamus | 2000 |
Neurobiology of behavioral changes after prenatal exposure to paroxetine (Paxil)
Topics: Animals; Antidepressive Agents, Second-Generation; Behavior, Animal; Female; Mice; Nervous System; Paroxetine; Pregnancy; Prenatal Exposure Delayed Effects | 2000 |
Nicotine exposure during pregnancy is a factor which influences serotonin transporter density in the rat brain.
Topics: Animals; Brain Chemistry; Carrier Proteins; Female; Infusion Pumps; Injections, Subcutaneous; Male; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Nicotine; Nicotinic Agonists; Paroxetine; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins | 2001 |
Withdrawal reactions of a premature neonate after maternal use of paroxetine.
Topics: Antidepressive Agents, Second-Generation; Female; Humans; Infant, Newborn; Infant, Premature; Neonatal Abstinence Syndrome; Paroxetine; Pregnancy; Prenatal Exposure Delayed Effects; Remission, Spontaneous | 2001 |
Fetal and adolescent nicotine administration: effects on CNS serotonergic systems.
Topics: Aging; Animals; Binding Sites; Brain; Carrier Proteins; Embryo, Mammalian; Female; Hydroxyindoleacetic Acid; Male; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Degeneration; Nerve Tissue Proteins; Nicotine; Paroxetine; Pregnancy; Prenatal Exposure Delayed Effects; Presynaptic Terminals; Radioligand Assay; Rats; Rats, Sprague-Dawley; Serotonin; Serotonin Plasma Membrane Transport Proteins; Sex Characteristics; Synaptic Transmission; Tobacco Use Disorder | 2001 |
Prenatal treatment with a selective D1 receptor agonist (SKF 38393) alters adult [3H]paroxetine binding and dopamine and serotonin behavioral sensitivity.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Behavior, Animal; Brain Stem; Cerebral Cortex; Conditioning, Operant; Dopamine; Female; Kinetics; Paroxetine; Piperidines; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Inbred Strains; Serotonin | 1990 |